Abstract from Nature, 29/5/19 - Unfortunately the whole article is behind a paywall.
"We used the indolent growth dynamics of chronic lymphocytic leukaemia (CLL) to analyse the growth rates and corresponding genomic patterns of leukaemia cells from 107 patients with CLL, spanning decades-long disease courses.
We found that CLL commonly demonstrates not only exponential expansion but also logistic growth, which is sigmoidal and reaches a certain steady-state level. Each growth pattern was associated with marked differences in genetic composition, the pace of disease progression and the extent of clonal evolution.
In a subset of patients, whose serial samples underwent next-generation sequencing, we found that dynamic changes in the disease course of CLL were shaped by the genetic events that were already present in the early slow-growing stages.
Finally, by analysing the growth rates of subclones compared with their parental clones, we quantified the growth advantage conferred by putative CLL drivers in vivo."
nature.com/articles/s41586-...
Another report on the same paper from Cancer Therapy Advisor states "Another interesting observation made in this study was related to an investigation of the growth dynamics of populations of subclones in these samples compared with their parental clones. One finding was that subclones acquiring additional CLL drivers had a fitness advantage in that they were more likely than the latter to exhibit accelerated growth, thereby demonstrating “ongoing evolution in vivo.”
cancertherapyadvisor.com/ho...
Jackie